comparemela.com

Latest Breaking News On - China coronavirus vaccine - Page 3 : comparemela.com

DNA Explainer: How China under President Xi Jinping is using COVID-19 vaccine as a political tool

DNA Explainer: How China under President Xi Jinping is using COVID-19 vaccine as a political tool . The virus that was named COVID-19 by the World Health Organisation has since disrupted the normal every day, claimed 1.9 million lives and devastate Share Updated: Jan 19, 2021, 10:03 AM IST The world kept battling with a new SARS-like virus throughout the 2020, that began in Wuhan, China. The virus that was named COVID-19 by the World Health Organisation has since disrupted the normal every day, claimed 1.9 million lives and devastated trade. Many countries are still desperately battling the virus as well as contending with its negative effect on business and trade.

China has given over 90 lakh Covid-19 vaccine doses: Report

China has given over 90 lakh Covid-19 vaccine doses: Report Premium Workers carry a container of coronavirus test samples outside of a residential neighborhood in Shijiazhuang in northern China s Hebei Province. (AP) . Updated: 09 Jan 2021, 08:46 AM IST Agencies Some 7.5 million doses have been administered since 15 December last year, officials said at a media briefing in Beijing Share Via Read Full Story As China braces for a possible increase in Covid-19 infections during the winter, the country has already administered over 9 million anti-coronavirus vaccine doses. Some 7.5 million doses have been administered since 15 December last year, officials said at a media briefing in Beijing.

China grants conditional approval to its homegrown Covid-19 vaccine

China has granted conditional approval to the country s first homegrown COVID-19 vaccine developed by state-owned pharmaceutical giant Sinopharm, an official announcement said on Thursday. The approval comes a day after Sinopharm said its vaccine showed 79.34 per cent efficacy and a 99.52 per cent antibody-positive conversion rate in the interim results of the Phase III clinical trials. The inactivated vaccine, developed by Beijing Biological Products Institute under Sinopharm s subsidiary China National Biotec Group (CNBG), got official authorisation from China s National Medical Products Administration on Wednesday, Chen Shifei, deputy head of the National Medical Products Administration, was quoted as saying by the state-run Global Times.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.